not tagged
not tagged
['melanoma']
1 in 5 #melanoma patients are identified as low risk by the #amlo biosciences ambra1 and loricrin test. discuss the test referral service with the team today at the int. congress of the
society for melanoma research, stand 9. 
Developing an innovative prognostic test for early-stage cutaneous melanoma